PMN ProMIS Neurosciences Inc.

Nasdaq promisneurosciences.com


$ 0.42 $ -0.03 (-6.22 %)    

Friday, 17-Oct-2025 15:59:16 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.4376
$ 0.45
$ 0.42 x 100
$ 0.51 x 31,848
$ 0.42 - $ 0.47
$ 0.38 - $ 1.59
457,183
na
22.67M
$ 21.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 08-14-2023 06-30-2023 10-Q
9 05-15-2023 03-31-2023 10-Q
10 03-08-2023 12-31-2022 10-K
11 11-14-2022 09-30-2022 10-Q
12 08-12-2022 06-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 promis-neurosciences-files-prospectus-of-282m-common-shares-offering-relates-to-resale-by-selling-securityholders

https://www.sec.gov/Archives/edgar/data/1374339/000155837025011875/pmn-20250904xs3.htm

 promis-neurosciences-files-for-mixed-shelf-of-up-to-50m

- SEC Filing

 promis-neurosciences-q2-eps-029-misses-017-estimate

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of...

 promis-neurosciences-to-present-precise-ad-trial-and-episelect-platform-at-aaic-2025

Presentation to highlight the Company's proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310Posters...

 promis-neurosciences-announces-private-investment-of-approximately-3m-of-warrants-sold-at-01875-per-share

The Warrants have an exercise price of $1.25 per Warrant Share, are immediately exercisable and will expire five years from the...

 why-vicor-shares-are-trading-higher-by-39-here-are-20-stocks-moving-premarket

Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results.

 hc-wainwright--co-initiates-coverage-on-promis-neurosciences-with-buy-rating-announces-price-target-of-4

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Buy rating...

 maxim-group-initiates-coverage-on-promis-neurosciences-with-buy-rating-announces-price-target-of-3

Maxim Group analyst Jason McCarthy initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Buy rating and announces P...

 promis-neurosciences-q1-eps-021-misses-012-estimate

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of...

 guggenheim-reiterates-buy-on-promis-neurosciences-maintains-6-price-target

Guggenheim analyst Eddie Hickman reiterates ProMIS Neurosciences (NASDAQ:PMN) with a Buy and maintains $6 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION